Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Prognostic Significance of Minimal Residual Disease in Multiple Myeloma in the Molecular Genetic Groups Msmart 3.0

Andrey Garifullin, MD, Sergei Voloshin, MD PhD, Sergey Linnikov, Irina Martynkevich, MD PhD, Alexey Kuvshinov, MD, Anastasiya Kuzyaeva, Zhanna Chubukina, Vasily Shuvaev, MD, Elizaveta Kleina, Marina Bakai, Alexander Sсhmidt

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-139239

Published: 2020

Journal Articles

Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma

Andrey Garifullin, MD, Sergei Voloshin, MD PhD, Vasily Shuvaev, MD, Irina Martynkevich, MD PhD, Elizaveta Kleina, Alexander Chechetkin, Stanislav Bessmeltcev, Anastasiya Kuzyaeva, Alexander Sсhmidt, Alexey Kuvshinov, MD, Irina Pavlova

Blood (2019) 134 (Supplement_1): 5593.

https://doi.org/10.1182/blood-2019-130092

Published: 2019

Journal Articles

Maintenance Therapy in Patients with Chronic Lymphocytic Leukemia Who Achieved MRD-Positive Remissions after Induction Therapy

Alexey Kuvshinov, MD, Sergei Voloshin, MD PhD, Vasily Shuvaev, MD, Elena Belyakova, MD, Mariia Mikhaleva, MD, Andrey Garifullin, MD, Georgiy Rysev, MD, Alexander Bogdanov, MD PhD, Irina Martynkevich, MD PhD, Elizaveta Kleina, Alena Samorodova, MD, Iuliia Ruzhenkova, Iuliia Vokueva, Alexander Chechetkin

Blood (2019) 134 (Supplement_1): 5475.

https://doi.org/10.1182/blood-2019-129995

Published: 2019

Journal Articles

Ibrutinib-Based Therapy in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia

Alexey Kuvshinov, Sergei Voloshin, Irina Martynkevich, DSc, Ludmila Martynenko, Andrei Garifullin, Elizaveta Kleina, Vasily Shuvaev, MD

Blood (2016) 128 (22): 5599.

https://doi.org/10.1182/blood.V128.22.5599.5599

Published: 2016

Journal Articles

Minimal Residual Disease in Multiple Myeloma Patients: Influence on Indicators of Progression Free Survival

Andrei Garifullin, Sergei Voloshin, Irina Martynkevich, DSc, Alexey Kuvshinov, Elizaveta Kleina, Vasily Shuvaev, MD, Kudrat Abdulkadyrov, Prof., MD PhD

Blood (2016) 128 (22): 5705.

https://doi.org/10.1182/blood.V128.22.5705.5705

Published: 2016

Journal Articles

Frequent Mutations and Their Influence on Prognosis in Patients with Acute Myeloid Leukemia

Ekaterina Petrova, Irina Martynkevich, MD PhD, Luybov Polushkina, Luydmila Martynenko, Marina Ivanova, Natalia Cybakova, Elizaveta Kleina, Elena Shabanova, Alexandr Chechetkin, Vasily Shuvaev, MD, Kudrat Abdulkadirov

Blood (2015) 126 (23): 4949.

https://doi.org/10.1182/blood.V126.23.4949.4949

Published: 2015

Journal Articles

The Impact of Genetic Abnormalities (GA) and Other Factors on Survival in Patients after 65 Years with Multiple Myeloma (MM)

Andrei Garifullin, Irina Martynkevich, MD PhD, Sergei Voloshin, Alexei Kuvshinov, Ludmila Martynenko, Elizaveta Kleina, Galina Salogub, Elena Karyagina, Alexander Schmidt, Kudrat Abdulkadyrov

Blood (2015) 126 (23): 5314.

https://doi.org/10.1182/blood.V126.23.5314.5314

Published: 2015

Journal Articles

The Frequency of Genetic Anomalies According to Clonal Plasma Cells' Phenotype in Patients with Newly Diagnosed (ND) Multiple Myeloma (MM)

Andrei Garifullin, Irina Martynkevich, MD PhD, Sergei Voloshin, Alexei Kuvshinov, Ludmila Martynenko, Elizaveta Kleina, Kudrat Abdulkadyrov

Blood (2015) 126 (23): 5316.

https://doi.org/10.1182/blood.V126.23.5316.5316

Published: 2015

Journal Articles

The Rate of Individual BCR-ABL Decline As an Optimized Predictor of Tyrosine Kinase Inhibitors Treatment Outcome in Chronic Phase CML Patients, Comparison with CML Prognostic Scores and Early Molecular Response Achievement

Blood (2015) 126 (23): 5150.

https://doi.org/10.1182/blood.V126.23.5150.5150

Published: 2015

Journal Articles

The Frequency of Occurrence of Minimal Residual Disease into Different Prognostic Groups of Patients with Chronic Lymphocytic Leukemia

Aleksei Kuvshinov, Sergei Voloshin, Irina Martynkevich, MD PhD, Ludmila Martynenko, Andrei Garifullin, Elizaveta Kleina, Kudrat Abdulkadyrov

Blood (2015) 126 (23): 5275.

https://doi.org/10.1182/blood.V126.23.5275.5275

Published: 2015

Journal Articles

Phenotypic Characteristics of Tumor Cells in Patients with Chronic Lymphocytic Leukemia into Different Prognostic Groups

Aleksei Kuvshinov, Sergei Voloshin, Irina Martynkevich, MD PhD, Ludmila Martynenko, Andrei Garifullin, Elizaveta Kleina, Kudrat Abdulkadyrov

Blood (2015) 126 (23): 5276.

https://doi.org/10.1182/blood.V126.23.5276.5276

Published: 2015

Journal Articles

Genetic and Epigenetic Alterations of Ph-Negative Myeloproliferative Neoplasms

Lyubov Polushkina, Irina Martynkevich, PhD, Vasily Shuvaev, MD, Ekaterina Petrova, Lyudmila Martynenko, Natalya Cybakova, MD, Marina Ivanova, MD, Elizaveta Kleina, Elena Shabanova, Dzhariyat Shikhbabaeva, Tatyana Zamotina, Mikhail Fominykh, Kudrat Abdulkadyrov, MD

Blood (2014) 124 (21): 5549.

https://doi.org/10.1182/blood.V124.21.5549.5549

Published: 2014

Journal Articles

Early Molecular Response in Chronic Myeloid Leukemia Patients Predicts Future Response Status

Irina Martynkevich, PhD, Vasily Shuvaev, MD, Ekaterina Petrova, Lyubov Polushkina, Lyudmila Martynenko, Marina Ivanova, MD, Natalya Cybakova, MD, Elizaveta Kleina, Elena Shabanova, Mikhail Fominykh, Kudrat Abdulkadyrov, MD

Blood (2014) 124 (21): 5529.

https://doi.org/10.1182/blood.V124.21.5529.5529

Published: 2014

Journal Articles

Prognostic Value of the Rate of BCR-ABL Decline for Patients with Chronic Myelogenous Leukemia in Chronic Phase on Tyrosine Kinase Inhibitors Treatment

Blood (2014) 124 (21): 3148.

https://doi.org/10.1182/blood.V124.21.3148.3148

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The Prognostic Significance of Minimal Residual Disease in Multiple Myeloma in the Molecular Genetic Groups Msmart 3.0

Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma

Maintenance Therapy in Patients with Chronic Lymphocytic Leukemia Who Achieved MRD-Positive Remissions after Induction Therapy

Ibrutinib-Based Therapy in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia

Minimal Residual Disease in Multiple Myeloma Patients: Influence on Indicators of Progression Free Survival

Frequent Mutations and Their Influence on Prognosis in Patients with Acute Myeloid Leukemia

The Impact of Genetic Abnormalities (GA) and Other Factors on Survival in Patients after 65 Years with Multiple Myeloma (MM)

The Frequency of Genetic Anomalies According to Clonal Plasma Cells' Phenotype in Patients with Newly Diagnosed (ND) Multiple Myeloma (MM)

The Rate of Individual BCR-ABL Decline As an Optimized Predictor of Tyrosine Kinase Inhibitors Treatment Outcome in Chronic Phase CML Patients, Comparison with CML Prognostic Scores and Early Molecular Response Achievement

The Frequency of Occurrence of Minimal Residual Disease into Different Prognostic Groups of Patients with Chronic Lymphocytic Leukemia

Phenotypic Characteristics of Tumor Cells in Patients with Chronic Lymphocytic Leukemia into Different Prognostic Groups

Genetic and Epigenetic Alterations of Ph-Negative Myeloproliferative Neoplasms

Early Molecular Response in Chronic Myeloid Leukemia Patients Predicts Future Response Status

Prognostic Value of the Rate of BCR-ABL Decline for Patients with Chronic Myelogenous Leukemia in Chronic Phase on Tyrosine Kinase Inhibitors Treatment

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only